Tuesday, December 31, 2019

Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million

Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million Marionol capsules are used to treat the loss of appetite (anorexia) in AIDS patients and to treat nausea and vomiting in patients receiving chemotherapy.

from Moneycontrol Business News https://ift.tt/2rGFKLI

No comments:

Post a Comment

Vedanta, Hindustan Zinc shares fall after metals giant confirms ED visits to offices

Vedanta and Hindustan Zinc shares dipped after the Enforcement Directorate visited some of their offices as part of a FEMA probe. The compan...